Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Blogs Comment On Supreme Court Decisions, Obama Administration, Other Topics
The following summarizes selected women"s health-related blog entries. ~ "Just Released: Gains and Losses for Women in 2008-09 Supreme Court Decisions," National Women"s Law Center"s "Womenstake": The Supreme Court"s 2008-2009 term, which concluded Monday, included "several crucial decisions that demonstrate the impact of the court on women"s lives," according to the blog post, which summarizes a new analysis from NWLC on the cases. For example, the blog post says that the rulings in Fitzgerald v. Barnstable School Committee and Crawford v. Metropolitan Government of Nashville and Davidson County, Tenn., increased employees" protections against discrimination in the workplace. However, the rulings in Ricci v. DeStetano -- which overturned an appellate court"s anti-discrimination ruling -- and AT&T Corp. v. Hulteen -- which "permitted AT&T to pay women lower pension benefits for the rest of their lives" -- were "not as positive," the blog entry says. NWLC Co-President Marcia Greenberger said that the Supreme Court "ignored the realities of the workplace and the intent of Congress and ruled against female workers" in AT&T v. Hulteen. Greenberger also said that such cases "underscore why every seat on the Supreme Court is of paramount importance to women," adding that it is "absolutely critical" that Supreme Court nominees have "a strong commitment to upholding and enforcing women"s basic legal rights and protections" ("Womenstake," National Women"s Law Center, 6/29).~ "Waldman and Saletan: Oh What a Fine Bromance!" Jodi Jacobson, RH Reality Check: In a recent bloggingheads.tv chat on "common ground" in the abortion-rights debate, Slate columnist Will Saletan and Beliefnet Editor-in-Chief Steve Waldman "spent as much time as possible complimenting each other"s work" and "as little as possible on any real substance regarding reproductive health and choice issues," Jacobson writes. It is "clear that the Obama administration"s stated intention to create "a common ground platform"" on abortion rights has become "a full employment program for both Waldman and Saletan," she writes. Jacobson continues, "So perhaps the most striking thing about the conversation was that, in the end, they both effectively concluded that the common ground enterprise was a "just for show" political strategy," and that the "real strategies" necessary to reduce the need for abortion "are the very prevention programs least likely to be supported by the far right. (Revelation!)." She adds, "However, they came to this conclusion through the same faux-expert uninformed arguments that characterize their columns." During the "Will-interviews-Steve format," Saletan "revealed once again that there is no core philosophy or framework underlying his ever-shifting positions on choice and abortion," according to Jacobson. She adds that "Waldman, for his part, several times underscored what is clear from reading his work": that he "just throws things "out there" without considered thought" about what "might be good versus bad data, not understanding how to read evidence," and "oblivious or uncaring about the effects his free-form moralistic misinformation and opinions might actually have on an already polarized debate." According to Jacobson, "Public policies affecting sexual and reproductive health issues" should be "based first and foremost on public health and on promoting individual rights balanced by individual responsibilities," but "as anyone living on Planet Earth knows, sex and reproduction have become the front in a war waged by ultra-conservative religious and political forces for which Waldman serves as a paid flacky." She continues, "In fact, Waldman himself stated during the program: "I have a corporate interest in injecting religion into every debate."" Jacobson states, "Reading and watching this duo is like buying the OK! magazine version of the culture wars at the grocery store; they put whatever sells on the front cover, no matter the truth or consequences.

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
Novavax, Inc. (Nasdaq: NVAX) announced it has manufactured a virus-like particle (VLP) vaccine candidate against the H1N1 pandemic influenza virus under current good-manufacturing practices (cGMP) at its new vaccine manufacturing facility in Rockville, MD. This milestone was accomplished in only 11 weeks after receiving the gene sequence for the H1N1 strain from the U.S. Centers for Disease Control. The Company was able to reach this manufacturing goal by employing proprietary, novel production technology which is not dependent on growing influenza virus in eggs. Chicken eggs are used to produce almost all of the world"s influenza vaccine supply. In addition, Novavax has produced essential reagents for measuring vaccine potency. The Company also has plans to produce additional batches of the pandemic H1N1 VLP vaccine to support human clinical studies and stands ready to assist with additional public health needs in the US as well as foreign countries.
News of the day
New Model Suggests Role Of Low Vitamin D In Cancer Development
In studying the preventive effects of vitamin D, researchers at the Moores Cancer Center at the University of California, San Diego, have proposed a new model of cancer development that hinges on a loss of cancer cells" ability to stick together. The model, dubbed DINOMIT, differs substantially from the current model of cancer development, which suggests genetic mutations as the earliest driving forces behind cancer.
Public Health

Managing Acute Post-operative Pain In Hospital

Health professionals caring for patients with acute post-operative pain can improve pain management with a new drug use evaluation toolkit developed by the National Prescribing Service Ltd (NPS). The Acute postoperative pain drug use evaluation (DUE) toolkit can be used by hospitals to assess practices and ensure interventions lead to improvements in a patient"s experience of pain. It is designed to support surgical, anaesthetic, pharmacy and nursing staff in public and private hospitals to manage acute pain after surgery and assist hospitals to review practice when new drugs become available. "Health professionals, hospital and day surgery services that choose to use these res will be able to audit the quality of acute postoperative pain management by measuring key quality indicators, provide real-time reporting and feedback data in a format that supports educational quality improvement strategies," Ms Mackson said. The DUE toolkit was developed following a national quality improvement project on management of acute postoperative pain in 62 Australian public and private hospitals in 2006 and 2007 and includes an electronic data collection tool (e-DUE) and educational res. The e-DUE audit tool is a standalone windows application that provides a streamlined method of data entry and reporting of clinical measures that ensures both hospital and patient confidentiality. It measures 13 quality indicators including pain assessment, sedation scores and management of acute pain post-discharge. The educational res include: - a PowerPoint feedback presentation for hospital staff; - wall posters on pain assessment and prescribing of analgesia; - pain scales, assessment and a discharge checklist; - a patient brochure; and - a summary to be used in one-on-one education with clinical staff. "The technology allows for improved functionality and can be used more than once to store data in order to show comparisons between data collections." Ms Mackson said. The educational res in the toolkit were developed in consultation with the Australian and New Zealand College of Anaesthetists (ANZCA) and Faculty of Pain Medicine for the acute postoperative pain project. The electronic DUE toolkit is free and can be downloaded from here. National Prescribing Service Ltd


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009